HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Poirier, V. J. Articles by Vail, D. M. Search for Related Content PubMed PubMed Citation Articles by Poirier, V. J. Articles by Vail, D. M.

Piroxicam, Mitoxantrone, and Coarse Fraction Radiotherapy for the Treatment of Transitional Cell Carcinoma of the Bladder in 10 Dogs: A Pilot Study

From the School of Veterinary Medicine and the Comprehensive Cancer Center, University of Wisconsin-Madison, 2015 Linden Drive, Madison, Wisconsin 53706.

Ten dogs with transitional cell carcinoma (TCC) of the bladder were treated with a combination of once-weekly coarse fraction radiation therapy (six weekly fractions of 5.75 Gray [Gy]), mitoxantrone chemotherapy, and piroxicam. All dogs completed the radiation therapy protocol, and only minimal side effects were observed. Only two (22%) dogs achieved a measurable partial response; however, 90% of the dogs had amelioration of their urinary clinical signs. The median survival time for all dogs was 326 days. While this treatment protocol was well tolerated, the response rate and overall survival duration was not superior to reports using mitoxantrone and piroxicam without radiation therapy in dogs with TCC.

This article has been cited by other articles:

				M. C. McEntee Veterinary Radiation Therapy: Review and Current State of the Art J. Am. Anim. Hosp. Assoc., March 1, 2006; 42(2): 94 - 109. [Abstract] [Full Text] [PDF]